# Dose-Proportionality and Food Effect Study of TNX-102 SL

> **NCT04164719** · PHASE1 · COMPLETED · sponsor: **Tonix Pharmaceuticals, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** TNX-102 SL

## Key facts

- **NCT ID:** NCT04164719
- **Lead sponsor:** Tonix Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-14
- **Primary completion:** 2019-12-24
- **Final completion:** 2019-12-24
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04164719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04164719, "Dose-Proportionality and Food Effect Study of TNX-102 SL". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04164719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*